LexaGene in Boston Herald

by LexaGene | Feb 4, 2020 | Human Clinical Diagnostics

Home » Human Clinical Diagnostics » LexaGene in Boston Herald

LexaGene CEO Dr. Jack Regan quoted as a virologist and influenza expert in the Boston Herald on the challenges of self-quarantine measures during the 2019 coronavirus outbreak.

Read the Full Article Here

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Subscribe for Updates

Upcoming Events

BioFuture

NYC
October 05, 2021 - October 06, 2021

The in-person and virtual event held in New York City attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions.

See All Events

Latest Resources

Sorry, we don't have any content in this category with that format. Is there anything we can help you with?

See All Resources